Clinical Trials
All Clinical Trials - Page 40 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03472846Phase 4Completed
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
Teriparatide
- NCT03071172Phase 3Unknown
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
Gonadorelin
- NCT02941367Phase 4Completed
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
Lixisenatide
- NCT03043807Phase 2Completed
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Gonadorelin
- NCT04060043EARLY_Phase 1Completed
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer
Gonadorelin
- NCT02735031Phase 2/Phase 3Completed
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Exenatide
- NCT02239523N/ACompleted
Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis
Teriparatide
- NCT03041792Phase 1Completed
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
Liraglutide
- NCT04296149Phase 2Completed
Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe
Octreotide
- NCT02572323Phase 2Completed
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
Tesamorelin
- NCT02896192Phase 3Completed
Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity
Setmelanotide
- NCT03013543Phase 2Completed
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
Setmelanotide
- NCT02963922Phase 3Completed
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
Liraglutide
- NCT02963935Phase 3Completed
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Liraglutide
- NCT03021187Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
Semaglutide
- NCT03049189Phase 3Active Not Recruiting
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Octreotide
- NCT03018665Phase 4Unknown
A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
Exenatide
- NCT03054662N/ACompleted
Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
Desmopressin
- NCT02814123Phase 2Completed
Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes
Pramlintide
- NCT02980666Phase 3Completed
Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support
Teduglutide
- NCT02860923Phase 3Completed
Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
Exenatide
- NCT03051009Phase 3Completed
Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
Desmopressin
- NCT03018028Phase 3Completed
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
Semaglutide
- NCT03015220Phase 3Completed
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
Semaglutide
- NCT02821819Phase 4Terminated
Random-start Ovarian Stimulation in Egg-donors (ROSE)
Gonadorelin
- NCT03029351Phase 4Terminated
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
Exenatide
- NCT02954458Phase 3Completed
Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
Teduglutide
- NCT02933411N/AUnknown
Low VW Activity in Adolescent HMB
Desmopressin
- NCT05577806N/ACompleted
DYG Versus Cetrorelix in Oocyte Donation
Gonadorelin
- NCT03692143N/AActive Not Recruiting
Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP
Teriparatide
- NCT03031535Phase 1Completed
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
Octreotide
- NCT03115307Phase 4Completed
Luteal Phase Support in Insemination Cycles
Gonadorelin
- NCT03233178N/ACompleted
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
Liraglutide
- NCT03038620Phase 4Completed
Impact of Liraglutide 3.0 on Body Fat Distribution
Liraglutide
- NCT03011021Phase 1/Phase 2Unknown
Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
Liraglutide
- NCT03011008Phase 4Unknown
Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
Liraglutide
- NCT02977897N/AUnknown
Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide
Octreotide
- NCT03013387Phase 2Withdrawn
Dosimetry Guided PRRT With 90Y-DOTATOC
Octreotide
- NCT02970591N/ACompleted
A Comparison of Three Different Treatment Options for Irritable Bowel Syndrome
Linaclotide
- NCT02963766Phase 3Completed
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Dulaglutide
- NCT03199261Phase 1Completed
A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects
Exenatide
- NCT02967757N/ACompleted
In-market Utilisation of Liraglutide Used for Weight Management in Europe
Liraglutide
- NCT02488512Phase 2Terminated
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
Octreotide
- NCT02837783Phase 4Terminated
A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)
Linaclotide
- NCT02949362Phase 3Completed
Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
Teduglutide
- NCT02972645Phase 1Completed
A Study of LY3305677 in Healthy Participants
Mazdutide
- NCT02973321Phase 2Completed
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT02976038Phase 2Terminated
Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
Elamipretide
- NCT04846218N/ACompleted
Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle
Gonadorelin
- NCT02940535N/AUnknown
Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response
Gonadorelin